Toxicological analysis of the chronic consumption of diheptanoin and triheptanoin in rats

International Journal of Food Science and Technology

Volumn 44, Issue 3, 2009, Pages 484-492

  Ataíde, T Da R ^a   De Oliveira, S L ^a   Da Silva, F M ^a   Vitorino Filha, L G C ^a   Tavares, M C Do N ^a   Sant'Ana, A E G ^a  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

Author keywords

Diheptanoin; Medium chain triacylglycerols; Toxicological analysis; Triheptanoin

Indexed keywords

GLYCINE MAX; RATTUS; RATTUS NORVEGICUS;

EID: 59649106101     PISSN: 09505423     EISSN: 13652621     Source Type: Journal    
DOI: 10.1111/j.1365-2621.2008.01757.x     Document Type: Article

References (40)

1. Águila, M.B., Loureiro, C.C., Pinheiro, A. da R. Mandarim-de-Lacerda, C.A. (2002). Lipid metabolism in rats fed diets containing different types of lipids. Arquivos Brasileiros de Cardiologia, 78, 32 38.
2. Akiyama, T., Tachibana, I., Shirohara, H., Watanabe, N. Otsuki, M. (1996). High-fat hypercaloric diet induces obesity, glucose intolerance and hyperlipidemia in normal adult male Wistar rat. Diabetes Research and Clinical Practice, 31, 27 35.
3. Araújo, R.S. (2002). Estudo Toxicológico das Drogas. In : Farmacologia (edited by P. Silva). Pp. 166 183. Rio de Janeiro : Guanabara Koogan.
4. Association of Official Analytical Chemists, AOAC (1990a). Protein efficiency ratio. Rat bioassay 960.48. In : AOAC Official Methods of Analysis, Chap. 45. Washington, DC : Association of Analytical Chemists.
5. Association of Official Analytical Chemists, AOAC (1990b). Protein (total) in flour 920.87. In : AOAC Official Methods of Analysis, Chap. 32. Washington, DC : Association of Analytical Chemists.
6. Ataíde, T.R., Lima, M.R.F., Valentim, I.B., Pinheiro, D.M. Sant'Ana, A.E.G 2007). Chemical synthesis of tricaproin, trienantin and tricaprylin. International Journal of Food Science and Technology, 42, 1504 1508.
7. Bivin, W.S., Crawford, M.P. Brewer, N.R. (1979). Morphophysiology. In : The Laboratory Rat, Vol. 1 (edited by H.J. Baker J.R. Lindsey). Pp. 73 103. New York, NY : Academic Press.
8. Bligh, E.G. Dyer, W.J. (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911 917.
9. den Boer, M., Voshol, P.J., Kuipers, F., Havekes, L.M. Romijn, J.A. (2004). Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arteriosclerosis Thrombosis and Vascular Biology, 24, 644 649.
10. Brunengraber, H. Roe, C.R. (2006). Anaplerotic molecules: current and future. Journal of Inherited Metabolic Disease, 29, 327 331.
11. Chanez, M., Bois-Joyeux, B., Arnaud, M.J. Peret, P. (1991). Metabolic effects in rats of a diet with a moderate level of medium-chain triglycerides. Journal of Nutrition, 121, 585 594.
12. Chengelis, C.P., Kirkpatrick, J.B., Marit, G.B., Morita, O., Tamaki, Y. Suzuki, H. (2006a). A chronic dietary toxicity study of DAG (diacylglycerol) in Beagle dogs. Food and Chemical Toxicology, 44, 81 97.
13. Chengelis, C.P., Kirkpatrick, J.B., Bruner, R.H. et al. (2006b). A 24-month dietary carcinogenicity study of DAG (diacylglycerol) in mice. Food and Chemical Toxicology, 44, 122 137.
14. Chengelis, C.P., Kirkpatrick, J.B., Bruner, R.H. et al. (2006c). A 24-month dietary carcinogenicity study of DAG (diacylglycerol) in rats. Food and Chemical Toxicology, 44, 98 121.
15. Colichon, Y.A., Torezan Filho, M. Strauss, I.E. (2001). Métodos diagnósticos: provas de função hepática. In : Doenças do Fígado e Vias Biliares (edited by L.C. da C. Gayotto V.A.F. Alves). Pp. 139 419. São Paulo : Atheneu.
16. Cosmetic Ingredient Review (2001). Final report on the safety assessment of trilaurin, triarachidin, tribehenin, tricaprin, tricaprylin, trierucin, triheptanoin, triheptylundecanoin, triisononanoin, triisopalmitin, triisostearin, trilinolein, trimyristin, trioctanoin, triolein, tripalmitin, tripalmitolein, tririconolein, tristearin, triundecanoin, glyceryl triacetyl hydroxystearate, glyceryl triacetyl ricinoleate, and glyceryl stearate diacetate. International Journal of Toxicology, 20, 61 94.
17. Friedewald, W.T., Levy, R.I. Fredrickson, D.S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499 502.
18. German, J.B. Dillard, C.J. (2004). Saturated fats: what dietary intake? American Journal of Clinical Nutrition, 80, 550 559.
19. Gilani, G.S., Ratnayake, W.M.N., Brooks, S.P.J., Botting, H.G., Plouffe, L.J. Lampi, B.J. (2002). Effects of dietary protein and fat on cholesterol and fat metabolism in rats. Nutrition Research, 22, 297 311.
20. Han, J., Hamilton, J.A., Kirkland, J.L., Corkey, B.E. Guo, W. (2003). Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. Obesity Research, 11, 734 744.
21. Hashim, S.A. Tantibhedyangkul, P. (1987). Medium chain triglyceride in early life: effects on growth of adipose tissue. Lipids, 22, 429 434.
22. Hill, J.O., Peters, J.C., Swift, L.L. et al. (1990). Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. Journal of Lipid Research, 31, 407 416.
23. Kelly, D.E., Mokan, M., Simoneau, J.A. Mandarino, L.J. (1993). Interaction between glucose and free fatty acid metabolism in human skeletal muscle. Journal of Clinical Investigation, 92, 91 98.
24. Kossoff, E.H. (2004). More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurology, 3, 415 420.
25. Koteish, A. Diehl, A.M. (2001). Animal models of steatosis. Seminars in Liver Disease, 21, 89 104.
26. Koteish, A. Diehl, A.M. (2002). Animal models of steatohepatitis. Best Practice & Research: Clinical Gastroenterology, 16, 679 690.
27. Mak, S.C., Chi, C.S. Wan, C.J. (1999). Clinical experience of ketogenic diet on children with refractory epilepsy. Acta PaediatricaTaiwan, 40, 97 100.
28. Marchesini, G., Brizi, M., Bianchi, G. et al. (2001). Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 50, 1844 1850.
29. Mochel, F., DeLonlay, P., Touati, G. et al. (2005). Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Molecular Genetics and Metabolism, 84, 305 312.
30. Morris, A 2003). Treatment of fatty acid oxidation defects: recent developments. British Inherited Metabolic Disease Group Bulletin, Autumn, 7 12.
31. Pinheiro, D.C.S.N., Favali, C.B.F., Souza Filho, A.A., da Silva, A.C.M., Filgueiras, T.M. Lima, M.G.S 1997/1998). Parâmetros Hematológicos de Camundongos e Ratos do Biotério Central da Universidade Federal do Ceará. Boletim Informativo do Colégio Brasileiro de Experimentação Animal, 3, 6 9.
32. Reeves, P.G. (1997). Components of the AIN-93 diets as improvements in the AIN-76 a diet. Journal of Nutrition, 127, 838S 841S.
33. Rencher, A.C 2002). Methods of Multivariate Analysis, 2nd edn. New York, NY : Wiley-Interscience.
34. Roe, C.R. Mochel, F. (2006). Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. Journal of Inherited Metabolic Disease, 29, 332 340.
35. Roe, C.R., Sweetman, L., Roe, D.S., David, F. Brunengraber, H. (2002). Treatment of cardiomyopathy andrhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. Journal of Clinical Investigation, 110, 259 269.
36. Scheen, A.J. Luyckx, F.H. (2002). Obesity and liver disease. Best Practice & Research Clinical Endocrinology & Metabolism, 16, 703 716.
37. St-Onge, M-P. Jones, P.J.H. (2002). Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. Journal of Nutrition, 132, 329 332.
38. Taha, A.Y., Ryan, M.A.A. Cunnane, S.C. (2005). Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism Clinical and Experimental, 54, 1127 1132.
39. Traul, K.A., Driedger, A., Ingle, D.L. Nakhasi, D. (2000). Toxicologic properties of medium-chain triglycerides. Food and Chemical Toxicology, 38, 79 98.
40. Vieira, S 2004). Bioestatística: Tópicos Avançados, 2nd edn. Rio de Janeiro : Elsevier.